Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Do Hedge Funds and Insiders Love Neenah Paper, Inc. (NP)?

Page 1 of 2

Neenah Paper, Inc. (NYSE:NP) has seen a decrease in hedge fund sentiment recently.

Neenah Paper

In the financial world, there are plenty of methods investors can use to analyze Mr. Market. A duo of the most underrated are hedge fund and insider trading movement. At Insider Monkey, our research analyses have shown that, historically, those who follow the top picks of the best fund managers can trounce the broader indices by a solid amount (see just how much).

Just as beneficial, optimistic insider trading sentiment is another way to break down the financial markets. Obviously, there are plenty of reasons for a corporate insider to downsize shares of his or her company, but just one, very clear reason why they would behave bullishly. Several academic studies have demonstrated the impressive potential of this method if investors know where to look (learn more here).

With these “truths” under our belt, let’s take a look at the key action surrounding Neenah Paper, Inc. (NYSE:NP).

Hedge fund activity in Neenah Paper, Inc. (NYSE:NP)

Heading into 2013, a total of 6 of the hedge funds we track were bullish in this stock, a change of 0% from one quarter earlier. With hedge funds’ sentiment swirling, there exists an “upper tier” of key hedge fund managers who were increasing their holdings meaningfully.

According to our comprehensive database, Cliff Asness’s AQR Capital Management had the most valuable position in Neenah Paper, Inc. (NYSE:NP), worth close to $2.5 million, comprising less than 0.1%% of its total 13F portfolio. Coming in second is Millennium Management, managed by Israel Englander, which held a $1.7 million position; the fund has less than 0.1%% of its 13F portfolio invested in the stock. Other hedge funds that are bullish include Gregory Fraser, Rudolph Kluiber, and Timothy Kroch’s GRT Capital Partners, J. Alan Reid, Jr.’s Forward Management and Ken Griffin’s Citadel Investment Group.

Judging by the fact that Neenah Paper, Inc. (NYSE:NP) has experienced bearish sentiment from the aggregate hedge fund industry, logic holds that there was a specific group of hedgies that decided to sell off their positions entirely at the end of the year. It’s worth mentioning that Alexander Mitchell’s Scopus Asset Management dropped the largest stake of all the hedgies we track, worth about $2.9 million in stock., and Mike Vranos of Ellington was right behind this move, as the fund dropped about $0.2 million worth. These transactions are interesting, as total hedge fund interest stayed the same (this is a bearish signal in our experience).

How have insiders been trading Neenah Paper, Inc. (NYSE:NP)?

Insider buying is at its handiest when the company we’re looking at has seen transactions within the past six months. Over the last half-year time period, Neenah Paper, Inc. (NYSE:NP) has seen zero unique insiders purchasing, and 3 insider sales (see the details of insider trades here).

Let’s go over hedge fund and insider activity in other stocks similar to Neenah Paper, Inc. (NYSE:NP). These stocks are Buckeye Technologies Inc. (NYSE:BKI), P.H. Glatfelter Company (NYSE:GLT), Boise Inc. (NYSE:BZ), Mercer International Inc. (NASDAQ:MERC), and Wausau Paper Corp. (NYSE:WPP). This group of stocks belong to the paper & paper products industry and their market caps are closest to NP’s market cap.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!